Literature DB >> 18497082

Sex hormone-binding globulin influences gene expression of LNCaP and MCF-7 cells in response to androgen and estrogen treatment.

Scott M Kahn1, Yu-Hua Li, Daniel J Hryb, Atif M Nakhla, Nicholas A Romas, Janice Cheong, William Rosner.   

Abstract

Sex hormone-binding globulin (SHBG), a plasma protein that binds androgens and estrogens, also participates in the initial steps of a membrane-based steroid signaling pathway in human prostate and breast. We have recently shown that SHBG is expressed at the mRNA and protein levels in the prostate and breast. In this study, we addressed whether locally expressed SHBG: (1) Functions to regulate activation of membrane-based steroid signaling and (2) influences activation of the androgen (AR) and estrogen (ER) receptors. Using microarray analysis, we identified specific genes that are influenced by SHBG expression in LNCaP and MCF-7 cells in a manner consistent with each of these properties. These findings suggest that locally expressed SHBG can play a functional role in the steroid responsiveness of prostate and breast cells through multiple signaling pathways and that perturbations in local SHBG expression could contribute to prostate and breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497082     DOI: 10.1007/978-0-387-69080-3_57

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin.

Authors:  Catherine Duggan; Jean de Dieu Tapsoba; Frank Stanczyk; Ching-Yun Wang; Karen Foster Schubert; Anne McTiernan
Journal:  Menopause       Date:  2019-04       Impact factor: 2.953

Review 2.  Use of testosterone replacement therapy in patients with prostate cancer.

Authors:  Tanya B Dorff; Nicholas J Vogelzang
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

3.  Associations of sex steroid hormones with mortality in women with breast cancer.

Authors:  Catherine Duggan; Frank Stanczyk; Kristin Campbell; Marian L Neuhouser; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2016-02-10       Impact factor: 4.872

4.  A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Authors:  Cynthia A Thomson; H H Sherry Chow; Betsy C Wertheim; Denise J Roe; Alison Stopeck; Gertraud Maskarinec; Maria Altbach; Pavani Chalasani; Chuan Huang; Meghan B Strom; Jean-Philippe Galons; Patricia A Thompson
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

5.  Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue.

Authors:  Ye Zhou; Maya Otto-Duessel; Miaoling He; Susan Markel; Tim Synold; Jeremy O Jones
Journal:  J Mol Endocrinol       Date:  2013-06-29       Impact factor: 5.098

6.  Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.

Authors:  Zbigniew P Kortylewicz; Jessica Nearman; Janina Baranowska-Kortylewicz
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

7.  Dietary beta-tocopherol and linoleic acid, serum insulin, and waist circumference predict circulating sex hormone-binding globulin in premenopausal women.

Authors:  Fatima Nayeem; Manubai Nagamani; Karl E Anderson; Yafei Huang; James J Grady; Lee-Jane W Lu
Journal:  J Nutr       Date:  2009-04-01       Impact factor: 4.798

8.  Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations.

Authors:  Ruixia Huang; Yuanyuan Ma; Ruth Holm; Claes G Trope; Jahn M Nesland; Zhenhe Suo
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

9.  Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells.

Authors:  Huika Li; Thy Pham; Brett C McWhinney; Jacobus P Ungerer; Carel J Pretorius; Derek J Richard; Robin H Mortimer; Michael C d'Emden; Kerry Richard
Journal:  Int J Endocrinol       Date:  2016-11-20       Impact factor: 3.257

10.  SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas.

Authors:  Yuanyuan Ma; Dongming Liang; Jian Liu; Jian-Guo Wen; Einar Servoll; Gudmund Waaler; Thorstein Sæter; Karol Axcrona; Ljiljana Vlatkovic; Ulrika Axcrona; Elisabeth Paus; Yue Yang; Zhiqian Zhang; Gunnar Kvalheim; Jahn M Nesland; Zhenhe Suo
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.